FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to an isolated fused protein containing at least one human alpha-1-antitrypsin polypeptide functionally associated with a modified human IgG4 Fc polypeptide.
EFFECT: invention is effective for inhibiting or down-regulating impaired expression or activity of serine protease in a subject in need thereof.
10 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2012 |
|
RU2698655C2 |
FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF | 2019 |
|
RU2728861C1 |
POLYVALENT AND POLYSPECIFIC GITR-BINDING FUSED PROTEINS | 2016 |
|
RU2753439C2 |
FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE | 2019 |
|
RU2824402C2 |
HERPES VACCINE | 2019 |
|
RU2731073C1 |
METHODS OF TREATING TISSUE CALCIFICATION | 2015 |
|
RU2770698C2 |
EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
FUSED POLYPEPTIDE WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2754466C2 |
POLYVALENT AND POLYSPECIFIC OX40-BINDING FUSED PROTEINS | 2017 |
|
RU2773052C2 |
RECOMBINANT PROTEINS WITH CCN DOMAINS AND FUSION PROTEINS | 2020 |
|
RU2825102C2 |
Authors
Dates
2021-04-15—Published
2015-10-27—Filed